Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4580 +0.0286 (+6.66%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 15, 2023

Via Benzinga

Ensysce Biosciences Receives Positive Nasdaq Listing Determination

February 15, 2023

Via ACCESSWIRE

Ensysce Biosciences to Present its Overdose Protection Program at the 4th Annual NIH 'HELPING END ADDICTION LONG-TERM' (HEAL) Meeting

February 14, 2023

Via ACCESSWIRE

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules

February 07, 2023

Via ACCESSWIRE

Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering

February 03, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Initiation of Final Stage of Groundbreaking Opioid Overdose Protection Phase 1 Study

January 25, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial

January 04, 2023

Via ACCESSWIRE

Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying ↗

February 02, 2023

The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence...

Via Benzinga

Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock

February 01, 2023

Via ACCESSWIRE

Why Ensysce Biosciences Stock Is Exploding Higher During Wednesday's Session ↗

January 25, 2023

Ensysce Biosciences Inc (NASDAQ: ENSC) shares are trading higher by 21.81% to $0.82 Wednesday after the company announced initiation of the final stage of its opioid overdose protection Phase 1 study....

Via Benzinga

Nasdaq Falls 50 Points; eHealth Shares Spike Higher ↗

January 25, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18....

Via Benzinga

Ensysce Biosciences's Return On Capital Employed Overview ↗

December 27, 2022

Via Benzinga

Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection

December 19, 2022

Via ACCESSWIRE

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings ↗

January 25, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 25, 2023

Via Benzinga

Ensysce Biosciences to Present at Diamond Equity Research 2023 Virtual Emerging Growth Invitational

January 23, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

Ensysce Biosciences Issues 2023 Shareholder Letter

January 11, 2023

Via ACCESSWIRE

Analyzing Ensysce Biosciences's Short Interest ↗

January 06, 2023

Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has fallen 83.99% since its last report. The company recently reported that it has 143 thousand shares sold short, which is 2.6% of all...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 28, 2022

Via Benzinga

How Is The Market Feeling About Ensysce Biosciences? ↗

December 21, 2022

Ensysce Biosciences's (NASDAQ:ENSC) short percent of float has risen 128.73% since its last report. The company recently reported that it has 315 thousand shares sold short, which is 16.24% of all...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 19, 2022

Via Benzinga

Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗

December 12, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

December 12, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.